Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000057

President, Research & Develop. sold 600 shares at $18.00 ($10,800)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2024-10-16 Sale 10b5-1 −600 $18.00 $10,800 183,216 D: show line 1 in the form
Open-market sales · 600 sh · avg $18.00 · $10,800
Loading xslF345X05/wk-form4_1729283492.xml…